Industry News & Updates

How are you minimising your potential personal liability for WHS legislation? With strict Workplace Health and Safety (WHS) legislation and severe penalties, including up to life imprisonment for industrial manslaughter offences, the potential implications for both individuals and organisations involved in serious workplace incidents are significant.

Under the Rail Safety National Law (RSNL), rail transport operators must ensure they effectively manage health-related risks affecting rail safety workers. The National Standard for Health Assessment of Rail Safety Workers serves as a comprehensive guide to help operators fulfill these regulatory requirements.

Cross-reactivity describes when an antibody interacts with a compound different from its intended antigen. In drug screening, cross-reactivity happens when an immunoassay test’s antibody binds to an antigen different from the drug it’s meant to detect. Antibodies bind to substances known as antigens in a specific manner, similar to how matching puzzle pieces fit together or a key fitting into a lock.

Companies are increasingly implementing drug and alcohol testing as understanding grows about their impact on workplace safety. While maintaining a secure work environment is a shared responsibility, understanding and following the new protocols can seem unclear, especially regarding the resources and regulatory evidence available.

The National Roads and Motorists’ Association (NRMA) has developed a report focused on identifying key factors contributing to road accidents and proposing potential measures to minimise fatalities and injuries. Ongoing support for law enforcement, infrastructure development and community awareness programs remains essential for enhancing road safety for all users.

Our Service Team is dedicated to maintaining your device to the highest standard for safety and reliability in alcohol and drug testing. Our expert service technicians work tirelessly to ensure that every device we service operates with precision and accuracy. From routine maintenance through to complex repairs, we are committed to supporting our clients with world class service, innovative solutions and technical support.

We have developed a resilient global supply chain with industry leading Australian manufacturing facilities & comprehensive and secure material resource planning. Our purpose built facilities include research laboratories, on-site calibration facilities and warehouse and production for our Australian designed, developed & produced products.

As temperatures warm, it’s important to remember the proper management and transportation requirements for heat-sensitive materials. This is particularly vital when handling and moving consumables for our Druglizer LE5 device. Utilising competitive lateral flow immunoassay methodology, the test strips within the cartridges are sensitive to temperature and require specific conditions for transportation, storage, and usage.

Passive testing for alcohol is a process where a sample of a subject’s breath is analysed without the use of a mouthpiece or any physical contact. It commonly involves a subject exhaling/blowing/talking within close proximity of an alcohol breath testing device.

In workplace testing, using different methods for screening and confirmation—like oral fluid for one and urine for the other—can lead to inconsistent results and confusion. Aligning both tests with the same method ensures accurate detection windows, reduces discrepancies, and strengthens the integrity of your testing program.

Workplace psychosocial hazards are related to the psychological and social conditions of the workplace rather than just the physical conditions. These include stress, fatigue, bullying, violence, aggression, harassment and burnout; all of which can be harmful to the health of employees and their wellbeing. There are also risk factors (ie the misuse of alcohol or other drugs) that can increase the likelihood of these hazards.

Currently organisations are facing a gap between Australia’s occupational health and safety laws and the use of medicinal cannabis. In January 2024, the number of Australians who were prescribed medicinal cannabis products was approx one million patients, according to Australian Health Practitioner Regulation Agency (AHPRA).